A focus on psychopharmacological agents, antipsychotics in particular, is featured in the Journal this month. Kendall (pp. [266a€“268][1]) argues that there is no clinical or scientific evidence to justify the notion that atypical antipsychotics represent a distinct antipsychotic class but rather
展开▼
